TERNS PHARMACEUTICALS INC (TERN)
US8808811074 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -88.07M | -90.21M | -60.35M | -50.16M | -40.57M | |||
| Depreciation Amortization | 325.00K | 292.00K | 480.00K | 510.00K | 390.00K | |||
| Income Taxes - Deferred | 143.00K | 141.00K | 390.00K | 220.00K | 690.00K | |||
| Change In Working Capital | -1.19M | 1.29M | -1.04M | -1.43M | 5.06M | |||
| Taxes Paid | N/A | 28.00K | 0.00 | 240.00K | 180.00K | |||
| Other non cash items | 14.03M | 21.10M | 11.40M | 9.03M | 4.62M | |||
| OPERATING CASH FLOW | -74.75M | -67.39M | -49.11M | -41.83M | -29.81M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -84.00K | -52.00K | -280.00K | -340.00K | -580.00K | |||
| Other Investing Activity | 129.25M | -37.94M | -22.00M | -119.36M | 7.28M | |||
| INVESTING CASH FLOW | 129.17M | -37.99M | -22.27M | -119.70M | 6.69M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -160.00K | 16.88M | |||
| Stock Issued/Repurchased | 177.63M | 42.30M | 167.50M | 137.28M | 69.50M | |||
| Other Financing Activity | -79.00K | -344.00K | -400.00K | -2.72M | -860.00K | |||
| FINANCING CASH FLOW | 177.55M | 41.95M | 167.10M | 134.39M | 85.52M | |||
| Exchange Rate Effect | 270.00K | 117.00K | -180.00K | -30.00K | 80.00K | |||
| CHANGE IN CASH | 232.24M | -63.31M | 95.54M | -27.17M | 62.48M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -74.75M | -67.39M | -49.11M | -41.83M | -29.81M | |||
| Capital Expenditure | -84.00K | -52.00K | -280.00K | -340.00K | -580.00K | |||
| FREE CASH FLOW | -74.84M | -67.44M | -49.39M | -42.17M | -30.39M | |||
All data in USD